School of Medicine
Showing 171-180 of 922 Results
-
Addy Cembellin-Kao
Administrative Associate 3, Emergency Medicine
Current Role at StanfordManage the Health Services Research Lab of Dr. Maya Yiadom, supporting faculty-led emergency medicine and health services research initiatives.
Lead the use of secure, HIPAA-compliant platforms (Smartsheet, REDCap, Nero Google Cloud Platform, Box, Google Drive, MS Office Suite) to streamline data and project management.
Ensure regulatory compliance across multi-site emergency medicine studies, maintaining IRB approvals, protocol adherence, and data security standards.
Implement workflow improvements in emergency department research operations, aligning study activities with clinical priorities and patient care delivery.
Support dissemination of research through manuscript coordination, abstract submissions, and grant preparation efforts. -
Sierra Mei Lin Centkowski, MD
Clinical Assistant Professor, Dermatology
Clinical Assistant Professor, DermatologyBioDr. Sierra Mei Lin Centkowski is a board-certified Clinical Assistant Professor of Dermatology at Stanford University. She received both her medical degree and Master’s in Bioethics from the Perelman School of Medicine at the University of Pennsylvania and completed her dermatology residency at Stanford. Her clinical interests include general dermatology, including skin cancer, acne, psoriasis, atopic dermatitis and dermatologic surgery. She believes that patient empowerment and partnership provide the foundation for effective, compassionate and holistic care.
-
Alma-Martina Cepika
Assistant Professor of Surgery (General Surgery)
Current Research and Scholarly InterestsCepika Lab studies human immune tolerance. Using cellular immunology, genomics, and gene engineering, we aim to understand: 1) the role of human thymic regulatory T cells (Tregs) and inducible type 1 regulatory T (Tr1) cells in resistance to anti-tumor immunity and cancer immunotherapy, and 2) the interplay between innate and adaptive immunity in the pathogenesis of human inflammatory bowel disease (IBD). Our overarching goal is to leverage our discoveries for improving patient outcomes.
